Sandra Okoye
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sandra Okoye has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Angel Ojimaojo Ekele1 shared publication
- Chidimma Ruth Chukwunwejim
Department of Pharmaceutical Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University, Awka, Anambra State, Nigeria, Nigeria
1 shared publication - Eddison Igho Oghonyon
Department of Pharmaceutical Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, David Umahi Federal University of Health Sciences, Uburu, Ebonyi State, Nigeria., Nigeria
1 shared publication - Israel Ojuade
Department of Microbiology, University of Lagos, Akoka, Nigeria
1 shared publication - Kingsley Chukwuebuka Agu
Nnamdi Azikiwe University, Awka, Nigeria, Nigeria
1 shared publication - Merylann Ochieng
Department of Biological Sciences, College of Liberal Arts and Sciences, Eastern Illinois University, Charleston, USA., USA
1 shared publication
Latest Publications
- Open Access
- 1 June 2026
- Published by Current Science Publishing in Journal of Environmental Science, Ecology and Chemistry
- Vol. 3 (1) , 23-39
Emerging nutrient removal technologies in wastewater treatment: Advancements in nitrogen and phosphorus management
- 1 June 2026
- Published by Current Science Publishing in Journal of Environmental Science, Ecology and Chemistry
- Vol. 3 (1) , 23-39
Open AccessEmerging nutrient removal technologies in wastewater treatment: Advancements in nitrogen and phosphorus management
- Open Access
- 28 October 2025
- Published by MDPI AG in Preprints.org
Larvicidal Efficacy of Plant-Mediated Silver Nanoparticles from Gmelina arborea and Hyptis suaveolens Against Wild Anopheles Vectors
Malaria remains a leading cause of morbidity and mortality in sub-Saharan Africa, with escalating insecticide resistance among Anopheles vectors threatening the sustainability of current control interventions. The search for novel, environmentally benign larvicidal agents has increasingly focused on nanotechnology innovations derived from medicinal plants. This study assessed the larvicidal potential of silver nanoparticles (AgNPs) synthesized using aqueous leaf extracts of Gmelina arborea and Hyptis suaveolens against wild Anopheles larvae collected from Lagos State, Nigeria. Fresh plant samples were authenticated botanically, and green synthesis of AgNPs was confirmed by a characteristic honey-brown colour change and UV–visible spectrophotometric analysis. Larvicidal bioassays were performed according to WHO guidelines using six graded concentrations under controlled insectary conditions. Mortality was recorded at 24, 48, and 72 hours, and toxicological responses were analyzed using probit regression in IBM SPSS v20. After 72 hours, both AgNP formulations demonstrated a concentration-dependent increase in larval mortality, with H. suaveolens AgNPs showing greater bioefficacy than G. arborea AgNPs. Specifically, H. suaveolens AgNPs achieved LC₅₀ and LC₉₅ values of 0.292 ppm and 1.948 ppm respectively, whereas LC₅₀ = 0.469 ppm and LC₉₅ = 3.919 ppm were recorded for G. arborea AgNPs. Control mortality remained ≤10%, validating experimental reliability. The potent larvicidal activity displayed by both plant-derived AgNPs suggests that phytochemical-mediated nanoparticle synthesis may enhance toxicity against mosquito vectors while retaining environmental safety. These findings provide evidence supporting the integration of green nanotechnology into vector-control strategies to help mitigate resistance to conventional insecticides and strengthen malaria prevention efforts in endemic communities.
- 28 October 2025
- Published by MDPI AG in Preprints.org
Open AccessLarvicidal Efficacy of Plant-Mediated Silver Nanoparticles from Gmelina arborea and Hyptis suaveolens Against Wild Anopheles Vectors
Malaria remains a leading cause of morbidity and mortality in sub-Saharan Africa, with escalating insecticide resistance among Anopheles vectors threatening the sustainability of current control interventions. The search for novel, environmentally benign larvicidal agents has increasingly focused on nanotechnology innovations derived from medicinal plants. This study assessed the larvicidal potential of silver nanoparticles (AgNPs) synthesized using aqueous leaf extracts of Gmelina arborea and Hyptis suaveolens against wild Anopheles larvae collected from Lagos State, Nigeria. Fresh plant samples were authenticated botanically, and green synthesis of AgNPs was confirmed by a characteristic honey-brown colour change and UV–visible spectrophotometric analysis. Larvicidal bioassays were performed according to WHO guidelines using six graded concentrations under controlled insectary conditions. Mortality was recorded at 24, 48, and 72 hours, and toxicological responses were analyzed using probit regression in IBM SPSS v20. After 72 hours, both AgNP formulations demonstrated a concentration-dependent increase in larval mortality, with H. suaveolens AgNPs showing greater bioefficacy than G. arborea AgNPs. Specifically, H. suaveolens AgNPs achieved LC₅₀ and LC₉₅ values of 0.292 ppm and 1.948 ppm respectively, whereas LC₅₀ = 0.469 ppm and LC₉₅ = 3.919 ppm were recorded for G. arborea AgNPs. Control mortality remained ≤10%, validating experimental reliability. The potent larvicidal activity displayed by both plant-derived AgNPs suggests that phytochemical-mediated nanoparticle synthesis may enhance toxicity against mosquito vectors while retaining environmental safety. These findings provide evidence supporting the integration of green nanotechnology into vector-control strategies to help mitigate resistance to conventional insecticides and strengthen malaria prevention efforts in endemic communities.
- Open Access
- 4 September 2025
- Published by MDPI AG in Preprints.org
Prevalence of Multidrug-Resistant Escherichia coli O157:H7 from Live Bird Markets in Lagos, Nigeria
Escherichia coli (E. coli), a gram-negative bacterium, is a major concern for human and animal health. While most E. coli strains are commensal, some can become dangerous pathogens causing intestinal and systemic illnesses. Poultry meat is a potential source of infection; as resistant E. coli can be transmitted to humans through the food chain. This study aimed to determine the prevalence and antibiotic resistance patterns of E. coli O157:H7 in poultry feces from a live bird market in Lagos, Nigeria.Samples were enriched in TSB (9 mL) at 37 °C for 18–24 h, plated onto EMB and SMAC agar, and presumptive E. coli O157 isolates (non-sorbitol fermenters) were confirmed by latex agglutination, following the manufacturer’s instructions. Antimicrobial susceptibility testing was performed on confirmed E. coli O157 isolates using the Kirby-Bauer disc diffusion method.A total of 180 poultry fecal samples were analyzed. Out of these, 105 (58.33%) were identified as Escherichia coli isolates. The isolation process further revealed that 74 (41.11%) of the isolates were non-sorbitol fermenters, and 26 (14.44%) were confirmed as Escherichia coli O157:H7 using the latex agglutination test. The isolates showed high resistance to most of the tested antibiotics.The findings indicate a high prevalence and a high level of multidrug resistance in E. coli O157:H7 from indigenous chickens in Lagos' live bird markets. The presence of these pathogenic and resistant organisms poses a significant public health risk to individuals with direct contact with the birds and to consumers in Nigeria.
- 4 September 2025
- Published by MDPI AG in Preprints.org
Open AccessPrevalence of Multidrug-Resistant Escherichia coli O157:H7 from Live Bird Markets in Lagos, Nigeria
Escherichia coli (E. coli), a gram-negative bacterium, is a major concern for human and animal health. While most E. coli strains are commensal, some can become dangerous pathogens causing intestinal and systemic illnesses. Poultry meat is a potential source of infection; as resistant E. coli can be transmitted to humans through the food chain. This study aimed to determine the prevalence and antibiotic resistance patterns of E. coli O157:H7 in poultry feces from a live bird market in Lagos, Nigeria.Samples were enriched in TSB (9 mL) at 37 °C for 18–24 h, plated onto EMB and SMAC agar, and presumptive E. coli O157 isolates (non-sorbitol fermenters) were confirmed by latex agglutination, following the manufacturer’s instructions. Antimicrobial susceptibility testing was performed on confirmed E. coli O157 isolates using the Kirby-Bauer disc diffusion method.A total of 180 poultry fecal samples were analyzed. Out of these, 105 (58.33%) were identified as Escherichia coli isolates. The isolation process further revealed that 74 (41.11%) of the isolates were non-sorbitol fermenters, and 26 (14.44%) were confirmed as Escherichia coli O157:H7 using the latex agglutination test. The isolates showed high resistance to most of the tested antibiotics.The findings indicate a high prevalence and a high level of multidrug resistance in E. coli O157:H7 from indigenous chickens in Lagos' live bird markets. The presence of these pathogenic and resistant organisms poses a significant public health risk to individuals with direct contact with the birds and to consumers in Nigeria.